US Stock MarketDetailed Quotes

ARAY Accuray

Watchlist
  • 1.685
  • +0.085+5.31%
Trading May 15 15:24 ET
167.23MMarket Cap-7659P/E (TTM)

Accuray Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-132.90%-8.1M
71.73%-5.09M
-18,776.09%-8.59M
747.46%15.54M
291.24%8.88M
213.13%24.63M
-155.24%-18.01M
100.53%46K
-106.23%-2.4M
-174.96%-4.64M
Net income from continuing operations
-1,158.76%-6.34M
-413.39%-9.62M
45.51%-2.97M
-73.56%-9.28M
25.96%-2.56M
157.27%599K
-1,146.93%-1.87M
-430.06%-5.45M
15.27%-5.35M
68.88%-3.45M
Operating gains losses
313.33%1.43M
-342.64%-1.44M
181.17%1.15M
-178.56%-2.43M
-1,141.24%-2.85M
-47.57%345K
-692.73%-326K
-80.52%409K
-62.02%3.09M
-97.04%274K
Depreciation and amortization
45.15%1.6M
34.32%1.55M
6.38%1.25M
-17.88%4.53M
-13.55%1.1M
-21.38%1.1M
-19.06%1.15M
-17.12%1.18M
-13.71%5.51M
-15.23%1.27M
Deferred tax
----
----
----
-74.45%456K
----
----
----
----
1,665.79%1.79M
----
Other non cash items
-2.07%236K
3.95%237K
8.68%238K
13.34%926K
6.73%238K
12.09%241K
2.24%228K
40.38%219K
-86.91%817K
-91.93%223K
Change In working capital
-142.77%-8.84M
103.29%711K
-41,300.00%-11.95M
120.46%4.62M
168.36%5.54M
177.91%20.66M
-179.74%-21.61M
100.19%29K
-389.77%-22.6M
-935.63%-8.11M
-Change in receivables
-83.22%2.23M
149.56%4.84M
-133.60%-5.2M
247.68%18.49M
93.90%-482K
275.40%13.27M
-180.49%-9.77M
268.51%15.47M
-339.14%-12.52M
53.39%-7.91M
-Change in inventory
-270.51%-8.03M
-204.14%-5.72M
27.83%-8.92M
70.01%-6.86M
138.18%2.68M
130.76%4.71M
-221.97%-1.88M
-490.30%-12.36M
-1,454.32%-22.86M
-180.59%-7.01M
-Change in prepaid assets
191.30%3.16M
1,312.13%3.7M
-11.22%-2.43M
33.32%-4.03M
156.62%1.92M
-93.83%-3.46M
-149.59%-305K
-46.81%-2.18M
-535.33%-6.04M
-115.81%-3.39M
-Change in payables and accrued expense
13.20%2.78M
51.25%-4.54M
13.86%4.81M
-79.65%3.74M
-26.92%6.37M
181.26%2.46M
-181.68%-9.31M
231.66%4.22M
346.63%18.36M
3.17%8.71M
-Change in other current liabilities
----
----
----
63.18%-324K
----
----
----
----
-32.73%-880K
-12.63%-214K
-Change in other working capital
-343.10%-8.97M
790.08%2.44M
95.84%-213K
-576.45%-6.39M
-372.52%-4.61M
103.14%3.69M
-129.32%-353K
-51.91%-5.12M
182.79%1.34M
110.97%1.69M
Cash from discontinued investing activities
Operating cash flow
-132.90%-8.1M
71.73%-5.09M
-18,776.09%-8.59M
747.46%15.54M
291.24%8.88M
213.13%24.63M
-155.24%-18.01M
100.53%46K
-106.23%-2.4M
-174.96%-4.64M
Investing cash flow
Cash flow from continuing investing activities
58.14%-795K
18.58%-1.25M
14.15%-1.09M
-168.84%-12.68M
-471.35%-7.98M
-78.81%-1.9M
-91.03%-1.53M
12.64%-1.27M
-96.62%-4.72M
-56.33%-1.4M
Net PPE purchase and sale
55.98%-795K
16.79%-1.25M
14.15%-1.09M
-167.42%-12.61M
-475.57%-8.04M
-70.06%-1.81M
-86.92%-1.5M
12.64%-1.27M
-103.32%-4.72M
-56.33%-1.4M
Net intangibles purchase and sale
--0
----
----
---67K
--0
---34K
----
----
--0
--0
Net business purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
58.14%-795K
18.58%-1.25M
14.15%-1.09M
-168.84%-12.68M
-471.35%-7.98M
-78.81%-1.9M
-91.03%-1.53M
12.64%-1.27M
-96.62%-4.72M
-56.33%-1.4M
Financing cash flow
Cash flow from continuing financing activities
0.00%-1.5M
-106.01%-257K
65.64%-1.5M
86.26%-2.11M
-470.21%-522K
-50.00%-1.5M
131.64%4.28M
-336.50%-4.37M
46.64%-15.37M
100.73%141K
Net issuance payments of debt
0.00%-1.5M
-142.86%-1.5M
65.64%-1.5M
79.66%-3.87M
-50.00%-1.5M
-50.00%-1.5M
121.88%3.5M
-336.50%-4.37M
-18.26%-19M
80.46%-1M
Net common stock issuance
----
----
----
-43.43%2.2M
----
----
----
----
135.19%3.89M
----
Proceeds from stock option exercised by employees
--0
----
----
----
----
--0
----
----
----
----
Net other financing activities
--0
----
----
-73.26%-447K
---83K
--0
----
----
84.72%-258K
--0
Cash from discontinued financing activities
Financing cash flow
0.00%-1.5M
-106.01%-257K
65.64%-1.5M
86.26%-2.11M
-470.21%-522K
-50.00%-1.5M
131.64%4.28M
-336.50%-4.37M
46.64%-15.37M
100.73%141K
Net cash flow
Beginning cash position
7.63%74.49M
-4.49%78.69M
1.16%91.2M
-23.73%90.15M
-8.50%90.85M
-44.50%69.21M
-22.63%82.39M
-23.73%90.15M
7.54%118.2M
-24.47%99.29M
Current changes in cash
-148.98%-10.4M
56.79%-6.6M
-100.02%-11.18M
103.32%746K
106.49%383K
189.08%21.23M
-183.47%-15.27M
49.43%-5.59M
-407.69%-22.49M
58.19%-5.9M
Effect of exchange rate changes
-571.12%-1.94M
14.61%2.4M
38.89%-1.33M
105.43%302K
99.04%-31K
126.09%412K
2,351.61%2.09M
-232.26%-2.17M
-666.29%-5.56M
-478.36%-3.24M
End cash Position
-31.59%62.15M
7.63%74.49M
-4.49%78.69M
1.16%91.2M
1.16%91.2M
-8.50%90.85M
-44.50%69.21M
-22.63%82.39M
-23.73%90.15M
-23.73%90.15M
Free cash flow
-139.05%-8.9M
67.56%-6.34M
-689.80%-9.68M
140.16%2.86M
114.01%846K
199.81%22.79M
-161.46%-19.55M
87.81%-1.23M
-119.66%-7.12M
-213.92%-6.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -132.90%-8.1M71.73%-5.09M-18,776.09%-8.59M747.46%15.54M291.24%8.88M213.13%24.63M-155.24%-18.01M100.53%46K-106.23%-2.4M-174.96%-4.64M
Net income from continuing operations -1,158.76%-6.34M-413.39%-9.62M45.51%-2.97M-73.56%-9.28M25.96%-2.56M157.27%599K-1,146.93%-1.87M-430.06%-5.45M15.27%-5.35M68.88%-3.45M
Operating gains losses 313.33%1.43M-342.64%-1.44M181.17%1.15M-178.56%-2.43M-1,141.24%-2.85M-47.57%345K-692.73%-326K-80.52%409K-62.02%3.09M-97.04%274K
Depreciation and amortization 45.15%1.6M34.32%1.55M6.38%1.25M-17.88%4.53M-13.55%1.1M-21.38%1.1M-19.06%1.15M-17.12%1.18M-13.71%5.51M-15.23%1.27M
Deferred tax -------------74.45%456K----------------1,665.79%1.79M----
Other non cash items -2.07%236K3.95%237K8.68%238K13.34%926K6.73%238K12.09%241K2.24%228K40.38%219K-86.91%817K-91.93%223K
Change In working capital -142.77%-8.84M103.29%711K-41,300.00%-11.95M120.46%4.62M168.36%5.54M177.91%20.66M-179.74%-21.61M100.19%29K-389.77%-22.6M-935.63%-8.11M
-Change in receivables -83.22%2.23M149.56%4.84M-133.60%-5.2M247.68%18.49M93.90%-482K275.40%13.27M-180.49%-9.77M268.51%15.47M-339.14%-12.52M53.39%-7.91M
-Change in inventory -270.51%-8.03M-204.14%-5.72M27.83%-8.92M70.01%-6.86M138.18%2.68M130.76%4.71M-221.97%-1.88M-490.30%-12.36M-1,454.32%-22.86M-180.59%-7.01M
-Change in prepaid assets 191.30%3.16M1,312.13%3.7M-11.22%-2.43M33.32%-4.03M156.62%1.92M-93.83%-3.46M-149.59%-305K-46.81%-2.18M-535.33%-6.04M-115.81%-3.39M
-Change in payables and accrued expense 13.20%2.78M51.25%-4.54M13.86%4.81M-79.65%3.74M-26.92%6.37M181.26%2.46M-181.68%-9.31M231.66%4.22M346.63%18.36M3.17%8.71M
-Change in other current liabilities ------------63.18%-324K-----------------32.73%-880K-12.63%-214K
-Change in other working capital -343.10%-8.97M790.08%2.44M95.84%-213K-576.45%-6.39M-372.52%-4.61M103.14%3.69M-129.32%-353K-51.91%-5.12M182.79%1.34M110.97%1.69M
Cash from discontinued investing activities
Operating cash flow -132.90%-8.1M71.73%-5.09M-18,776.09%-8.59M747.46%15.54M291.24%8.88M213.13%24.63M-155.24%-18.01M100.53%46K-106.23%-2.4M-174.96%-4.64M
Investing cash flow
Cash flow from continuing investing activities 58.14%-795K18.58%-1.25M14.15%-1.09M-168.84%-12.68M-471.35%-7.98M-78.81%-1.9M-91.03%-1.53M12.64%-1.27M-96.62%-4.72M-56.33%-1.4M
Net PPE purchase and sale 55.98%-795K16.79%-1.25M14.15%-1.09M-167.42%-12.61M-475.57%-8.04M-70.06%-1.81M-86.92%-1.5M12.64%-1.27M-103.32%-4.72M-56.33%-1.4M
Net intangibles purchase and sale --0-----------67K--0---34K----------0--0
Net business purchase and sale --------------0------------------0----
Cash from discontinued investing activities
Investing cash flow 58.14%-795K18.58%-1.25M14.15%-1.09M-168.84%-12.68M-471.35%-7.98M-78.81%-1.9M-91.03%-1.53M12.64%-1.27M-96.62%-4.72M-56.33%-1.4M
Financing cash flow
Cash flow from continuing financing activities 0.00%-1.5M-106.01%-257K65.64%-1.5M86.26%-2.11M-470.21%-522K-50.00%-1.5M131.64%4.28M-336.50%-4.37M46.64%-15.37M100.73%141K
Net issuance payments of debt 0.00%-1.5M-142.86%-1.5M65.64%-1.5M79.66%-3.87M-50.00%-1.5M-50.00%-1.5M121.88%3.5M-336.50%-4.37M-18.26%-19M80.46%-1M
Net common stock issuance -------------43.43%2.2M----------------135.19%3.89M----
Proceeds from stock option exercised by employees --0------------------0----------------
Net other financing activities --0---------73.26%-447K---83K--0--------84.72%-258K--0
Cash from discontinued financing activities
Financing cash flow 0.00%-1.5M-106.01%-257K65.64%-1.5M86.26%-2.11M-470.21%-522K-50.00%-1.5M131.64%4.28M-336.50%-4.37M46.64%-15.37M100.73%141K
Net cash flow
Beginning cash position 7.63%74.49M-4.49%78.69M1.16%91.2M-23.73%90.15M-8.50%90.85M-44.50%69.21M-22.63%82.39M-23.73%90.15M7.54%118.2M-24.47%99.29M
Current changes in cash -148.98%-10.4M56.79%-6.6M-100.02%-11.18M103.32%746K106.49%383K189.08%21.23M-183.47%-15.27M49.43%-5.59M-407.69%-22.49M58.19%-5.9M
Effect of exchange rate changes -571.12%-1.94M14.61%2.4M38.89%-1.33M105.43%302K99.04%-31K126.09%412K2,351.61%2.09M-232.26%-2.17M-666.29%-5.56M-478.36%-3.24M
End cash Position -31.59%62.15M7.63%74.49M-4.49%78.69M1.16%91.2M1.16%91.2M-8.50%90.85M-44.50%69.21M-22.63%82.39M-23.73%90.15M-23.73%90.15M
Free cash flow -139.05%-8.9M67.56%-6.34M-689.80%-9.68M140.16%2.86M114.01%846K199.81%22.79M-161.46%-19.55M87.81%-1.23M-119.66%-7.12M-213.92%-6.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cancer Research
Cancer Research
Intraday+0.97%